Pharmacotherapy Considerations in the Elderly Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Pharmacotherapy Considerations in the Elderly. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 1: A 40-year-old woman presents with double vision, difficulty swallowing, and drooping eyelids that worsen as the day progresses. Which class of medications is the most appropriate initial treatment?
- A. Calcium channel blockers
- B. Acetylcholinesterase inhibitors (Correct Answer)
- C. Dopamine agonists
- D. Beta blockers
Pharmacotherapy Considerations in the Elderly Explanation: The patient's symptoms (double vision, difficulty swallowing, drooping eyelids, worsening with activity) are classic for **myasthenia gravis** [1, 2], a disorder affecting the **neuromuscular junction**. **Acetylcholinesterase inhibitors** (e.g., pyridostigmine) increase the amount of **acetylcholine** in the synaptic cleft, improving muscle strength and function [1].
*Calcium channel blockers*
- These medications affect **calcium influx** into cells and are primarily used for cardiovascular conditions or certain neurological disorders like migraine.
- They do not directly address the underlying pathophysiology of **myasthenia gravis**.
*Dopamine agonists*
- **Dopamine agonists** are used to treat conditions like **Parkinson's disease**, which involves a deficiency of dopamine in the brain.
- They have no role in treating the autoantibody-mediated neuromuscular blockade seen in **myasthenia gravis**.
*Beta blockers*
- **Beta blockers** primarily act on **adrenergic receptors** and are used for conditions like hypertension, angina, and anxiety.
- They do not target the acetylcholine receptor dysfunction characteristic of **myasthenia gravis** and can potentially worsen muscle weakness in some patients.
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 2: A 72 year old lady is severely depressed. For the past 2 days she has suicidal thoughts with an actual intent to die. Which of the following is best suitable to alleviate the symptoms?
- A. ECT (Correct Answer)
- B. Selegiline
- C. Haloperidol + Chlorpromazine
- D. Amitriptyline
Pharmacotherapy Considerations in the Elderly Explanation: ***ECT (Electroconvulsive Therapy)***
- **ECT** is the most effective and rapid treatment for severe depression, especially when associated with active **suicidal ideation** and intent.
- Its quick onset of action (often within days) makes it vital in situations requiring urgent symptom alleviation to ensure patient safety.
- **First-line treatment** for geriatric depression with suicidal risk and when rapid response is needed.
*Selegiline*
- **Selegiline** is a monoamine oxidase inhibitor (MAOI) used for depression and Parkinson's disease, but its antidepressant effects are not immediate.
- It would not sufficiently address the patient's acute suicidal intent due to its slower therapeutic onset (several weeks).
*Haloperidol + Chlorpromazine*
- This combination consists of **antipsychotics**, primarily used for conditions with psychotic features or severe agitation but not as a primary treatment for severe depression with suicidal ideation.
- While they might provide some sedation, they do not treat the underlying depressive disorder effectively and rapidly enough to resolve acute suicidal intent.
*Amitriptyline*
- **Amitriptyline** is a tricyclic antidepressant (TCA) that can be effective for depression but has a delayed onset of action (2-4 weeks).
- **Highly contraindicated in suicidal patients** due to its extreme lethality in overdose (cardiotoxic effects).
- Its slow therapeutic effect would not be appropriate for an urgent situation involving active suicidal thoughts with intent.
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 3: Pharmacodynamics deals with:-
- A. Latency of onset
- B. Mechanism of action of a drug (Correct Answer)
- C. Transport of drug across the biological membranes
- D. Mode of excretion of a drug
Pharmacotherapy Considerations in the Elderly Explanation: Detailed study of the **Mechanism of action of a drug** [1][2]
- **Pharmacodynamics** describes what the **drug does to the body**, including its **molecular targets** and biochemical effects [3].
- This involves the study of the drug's mechanisms to produce its therapeutic or toxic effects [2].
*Latency of onset*
- **Latency of onset** refers to the time it takes for a drug to start producing its effects, which is a pharmacokinetic rather than a pharmacodynamic parameter.
- It deals with the drug's absorption and distribution rather than its interaction with the body once it reaches its site of action.
*Transport of drug across the biological membranes*
- The **transport of drugs across biological membranes** is a key aspect of **pharmacokinetics**, specifically absorption and distribution [1].
- This process determines how much drug reaches its target site, not how it interacts with the target.
*Mode of excretion of a drug*
- The **mode of excretion** of a drug (e.g., renal, hepatic) falls under **pharmacokinetics**, addressing how the body gets rid of the drug.
- This process influences the drug's duration of action and elimination half-life, not its mechanism of action.
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 4: Which of the following is the most appropriate treatment for an overactive bladder in a patient with dementia?
- A. Tolterodine (Correct Answer)
- B. Mirabegron
- C. Behavioral therapy/bladder training
- D. Oxybutynin
- E. Trospium
Pharmacotherapy Considerations in the Elderly Explanation: ***Tolterodine***
- **Tolterodine** is a **muscarinic antagonist** that blocks acetylcholine receptors in the bladder, reducing detrusor muscle contractions and overactive bladder symptoms.
- Unlike some other anticholinergics like oxybutynin, it has a **lower propensity to cross the blood-brain barrier** and thus a reduced risk of exacerbating cognitive impairment in patients with dementia.
*Mirabegron*
- **Mirabegron** is a **beta-3 adrenergic agonist** that relaxes the detrusor muscle, increasing bladder capacity.
- While it has a different mechanism of action and is less likely to cause anticholinergic cognitive side effects than older anticholinergics, it can still cause **hypertension** and **tachycardia**, which may be problematic in elderly patients with comorbidities.
*Behavioral therapy/bladder training*
- **Behavioral therapy** and **bladder training** are important first-line treatments for overactive bladder.
- However, for patients with **dementia**, cognitive impairment often makes adherence to and understanding of these complex therapies challenging or impossible without significant caregiver support.
*Oxybutynin*
- **Oxybutynin** is an **anticholinergic drug** that is effective for overactive bladder.
- However, it has a **high affinity for muscarinic receptors** in the brain and readily crosses the blood-brain barrier, significantly increasing the risk of **cognitive impairment, confusion, and delirium** in elderly patients, especially those with pre-existing dementia.
*Trospium*
- **Trospium** is a **quaternary amine anticholinergic** that is hydrophilic and has minimal blood-brain barrier penetration.
- While theoretically safer than oxybutynin in terms of CNS effects, it has **lower bladder selectivity** compared to tolterodine and may cause more peripheral anticholinergic side effects (dry mouth, constipation).
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 5: A drug is more likely to cause toxicity in elderly patients due to all of the following reasons except which of the following?
- A. decreased renal excretion of drugs
- B. decreased hepatic metabolism
- C. decreased volume of distribution (Correct Answer)
- D. increased receptor sensitivity
Pharmacotherapy Considerations in the Elderly Explanation: ***decreased volume of distribution***
- A **decreased volume of distribution** would generally lead to a higher peak plasma concentration for a given dose, potentially increasing drug effect and thus toxicity, particularly for **hydrophilic drugs**.
- However, for drugs that primarily distribute into **fat** or have a large volume of distribution, age-related changes in body composition (e.g., increased body fat, decreased total body water) can actually lead to an **increased volume of distribution** for some lipophilic drugs.
*decreased renal excretion of drugs*
- **Aging** is associated with a decline in **glomerular filtration rate (GFR)** and **renal tubular function**, leading to reduced drug clearance.
- This results in a longer **half-life** and accumulation of renally excreted drugs, increasing the risk of **toxicity**.
*decreased hepatic metabolism*
- Liver size, blood flow, and the activity of some **cytochrome P450 enzymes** may decrease with age.
- This leads to reduced **first-pass metabolism** and slower systemic clearance of many hepatically metabolized drugs, increasing their **bioavailability** and plasma concentrations.
*increased receptor sensitivity*
- Elderly patients often exhibit altered **pharmacodynamic responses**, including **increased sensitivity** to certain drugs.
- This means a lower concentration of the drug at the receptor site can produce a greater therapeutic or toxic effect, making them more susceptible to **adverse drug reactions**.
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 6: A 56-year-old woman has nausea due to chemotherapy for breast cancer. Droperidol is effective in reducing nausea because it blocks which of the following?
- A. Glucocorticoid receptors in the vomiting center
- B. Dopamine receptors in the CTZ (Correct Answer)
- C. ACh receptors in the periphery
- D. 5-HT3 receptors in the CTZ
Pharmacotherapy Considerations in the Elderly Explanation: **Dopamine receptors in the CTZ**
- Droperidol is a **butyrophenone antipsychotic** that acts as an **antidopaminergic agent**, primarily targeting **D2 dopamine receptors**.
- Its antiemetic effect is mainly due to blocking these **dopamine receptors in the chemoreceptor trigger zone (CTZ)**, which is involved in initiating the vomiting reflex.
*Glucocorticoid receptors in the vomiting center*
- **Glucocorticoids** like dexamethasone are used as antiemetics, but they act via **glucocorticoid receptors**, not through dopamine receptor blockade.
- Their mechanism involves inhibiting prostaglandin synthesis and inflammation, reducing the release of serotonin.
*ACh receptors in the periphery*
- Drugs that block **acetylcholine (ACh) receptors** (e.g., scopolamine) are used for motion sickness, but they are not the primary mechanism of action for droperidol.
- **Anticholinergics** typically exert their effects on the vestibular system and peripheral muscarinic receptors.
*5-HT 2 receptors in the CTZ*
- While some antiemetics (e.g., **ondansetron**) block **serotonin (5-HT3) receptors**, droperidol's primary action is not on **5-HT2 receptors**.
- **Serotonin antagonists** are particularly effective for chemotherapy-induced nausea and vomiting as chemotherapy often releases serotonin from enterochromaffin cells.
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 7: The drug that causes fall in elderly patients with postural hypotension is:-
- A. Acarbose
- B. Prazosin (Correct Answer)
- C. Nor-adrenaline
- D. Metformin
Pharmacotherapy Considerations in the Elderly Explanation: ***Prazosin***
- **Alpha-1 adrenergic blocker** used to treat hypertension and benign prostatic hyperplasia (BPH)
- Commonly causes **orthostatic hypotension (postural hypotension)** as a side effect by blocking alpha-1 receptors on vascular smooth muscle, preventing compensatory vasoconstriction upon standing
- Leads to **dizziness, lightheadedness, and falls**, especially in elderly patients who have reduced baroreceptor sensitivity
- **First-dose phenomenon** is particularly notable, with marked hypotension after the initial dose
*Acarbose*
- Alpha-glucosidase inhibitor used to treat type 2 diabetes by reducing carbohydrate absorption in the intestine
- Primary side effects are **gastrointestinal** (flatulence, diarrhea, abdominal discomfort)
- Does not affect blood pressure or cause postural hypotension
*Nor-adrenaline (Norepinephrine)*
- **Vasopressor** and sympathomimetic agent that causes vasoconstriction through alpha-adrenergic receptor stimulation
- **Increases blood pressure** and is used to treat severe hypotension in critical care settings
- Would not cause falls due to postural hypotension; rather, it counteracts hypotension
*Metformin*
- **Biguanide** oral hypoglycemic agent for type 2 diabetes that primarily decreases hepatic glucose production and increases insulin sensitivity
- Main side effects include gastrointestinal disturbances and rare lactic acidosis
- Not associated with postural hypotension or increased risk of falls
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 8: A 68-year-old with depression and chronic pain is on amitriptyline. What side effect may arise if given oxybutynin for overactive bladder?
- A. Severe dry mouth (Correct Answer)
- B. Bradycardia
- C. Increased sweating
- D. Urinary incontinence
Pharmacotherapy Considerations in the Elderly Explanation: ***Severe dry mouth***
- Both **amitriptyline** (a tricyclic antidepressant) and **oxybutynin** (an anticholinergic for overactive bladder) have significant anticholinergic effects.
- The combination of these two drugs can lead to an additive effect, causing pronounced anticholinergic side effects such as **severe dry mouth**, blurred vision, constipation, and cognitive impairment.
*Bradycardia*
- **Anticholinergic drugs** typically cause **tachycardia** (increased heart rate) by blocking the parasympathetic nervous system's muscarinic receptors on the heart, rather than bradycardia.
- While amitriptyline can affect cardiac conduction, severe bradycardia is not a typical **additive anticholinergic side effect** in this context.
*Increased sweating*
- **Anticholinergic drugs** like amitriptyline and oxybutynin inhibit the activity of sweat glands, which are primarily innervated by cholinergic nerves.
- Therefore, the combination of these drugs would likely lead to **decreased sweating** (anhidrosis) rather than increased sweating.
*Urinary incontinence*
- **Oxybutynin** is prescribed specifically to treat **overactive bladder** and reduce urinary incontinence by relaxing the detrusor muscle.
- Therefore, it would improve rather than worsen urinary incontinence; however, it can cause **urinary retention** due to its anticholinergic effect, especially in older male patients.
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 9: Which of the following is NOT true about delirium?
- A. Characterized by fluctuating consciousness
- B. Reversible with treatment
- C. Common in elderly patients
- D. It has a slow, insidious onset (Correct Answer)
Pharmacotherapy Considerations in the Elderly Explanation: ***It has a slow, insidious onset***
- Delirium is characterized by an **acute** or **subacute** onset, meaning it develops rapidly over hours to days, not slowly and insidiously.
- An insidious onset is more characteristic of **dementia**, which differs significantly from delirium in its course.
*Characterized by fluctuating consciousness*
- **Fluctuating consciousness** is a hallmark feature of delirium, where the level of awareness and cognitive function can change significantly throughout the day.
- Patients with delirium often exhibit periods of **lucidity** interspersed with confusion and disorientation.
*Reversible with treatment*
- Delirium is often **reversible** if the underlying causes, such as infection, metabolic imbalances, or medication side effects, are identified and treated promptly.
- This distinguishes it from **dementia**, which is generally a progressive and irreversible condition.
*Common in elderly patients*
- Delirium is indeed very **common in elderly patients**, particularly those with pre-existing cognitive impairment, multiple comorbidities, or those in critical care settings.
- Their physiological vulnerability makes them more susceptible to the stressors that can precipitate delirium.
Pharmacotherapy Considerations in the Elderly Indian Medical PG Question 10: Which of the following antidepressants can be safely used in elderly depression?
- A. Trazodone
- B. Mianserin (Correct Answer)
- C. Fluoxetine
- D. Phenelzine
Pharmacotherapy Considerations in the Elderly Explanation: In geriatric psychiatry, the choice of antidepressant is dictated by the side-effect profile, specifically the risk of anticholinergic effects, sedation, and cardiovascular complications.
**Why Mianserin is correct:**
Mianserin is a tetracyclic antidepressant (TeCA) that is frequently preferred in the elderly because it lacks significant **anticholinergic side effects** (which cause confusion, urinary retention, and glaucoma) and has minimal **cardiotoxicity**. It is particularly useful in elderly patients with insomnia or agitation due to its sedative properties, but it does not typically cause the severe orthostatic hypotension seen with older TCAs.
**Analysis of Incorrect Options:**
* **Fluoxetine (Option C):** While SSRIs are first-line for the elderly, Fluoxetine has a very **long half-life** (and active metabolites) which can lead to accumulation and prolonged side effects (like hyponatremia/SIADH or agitation) in patients with age-related renal or hepatic decline. Sertraline is generally preferred over Fluoxetine in this age group.
* **Trazodone (Option A):** Though used for sleep, it is notorious for causing significant **orthostatic hypotension** in the elderly, increasing the risk of falls and hip fractures.
* **Phenelzine (Option D):** As a non-selective MAOI, it requires strict dietary restrictions and carries a high risk of **hypertensive crisis** and drug-drug interactions, making it unsafe for the polypharmacy often seen in geriatric patients.
**NEET-PG High-Yield Pearls:**
* **Drug of Choice:** SSRIs (specifically **Sertraline** or **Escitalopram**) are generally the first-line treatment for elderly depression.
* **Mianserin Risk:** Always monitor for **agranulocytosis** (rare but serious).
* **Avoid:** Tertiary amines (Amitriptyline, Imipramine) due to high anticholinergic activity.
* **Key Concern:** Always check for **hyponatremia** (SIADH) when starting an SSRI in an elderly patient.
More Pharmacotherapy Considerations in the Elderly Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
